European Archives - Page 6 of 1585 - European Medical Journal

Cherry Angiomas Linked to Neurofibromatosis Type 1

Cherry angiomas were more prevalent in neurofibromatosis type 1, with NF1 alterations suggesting a vascular manifestation.

Low-Dose Hydrocortisone Improves Cognition in Women With HIV

In 81 women with HIV, a single 10 mg hydrocortisone dose improved attention at 30 minutes and 4 hours.

colorectal cancer

Brain Metastases Timing Predicts Colorectal Cancer Survival

Brain metastases occurred in 1.7% of patients with colorectal cancer, with de novo disease associated with substantially poorer overall survival.

Statins Reduce Cardiovascular Risk in Healthy Older Adults: ESC 2026

New STAREE trial data presented during ESC Congress 2026 showed atorvastatin reduced major cardiovascular events by 30% in adults aged 70 years and older.

Formaldehyde Contact Allergy Remains a Global Concern

A study of 1.3 million dermatitis patients revealed geographical differences in formaldehyde contact allergy.

New Myocardial Infarction Definition Simplifies Diagnosis: ESC 2026

A revised myocardial infarction classification, released during the ESC Congress 2026, replaces numerical labels with three clinical categories supporting more consistent diagnosis.

Epigenetic Clocks Reveal Disease-Driven Colon Ageing

A compact colon-specific epigenetic clock accurately predicted age and revealed accelerated ageing associated with HIV infection, IBD, and colonic polyps.

Alcohol Biomarker Identified Potential MetALD in MASLD

PEth was elevated in 11% of patients screened for MASLD trials, suggesting alcohol use warranting evaluation for possible MetALD or ALD.

New Assay Could Simplify HIV Drug Resistance Testing

An optimised reverse transcriptase assay detected very low HIV viral loads and phenotypic drug resistance in around 2 hours, potentially offering a more accessible approach to resistance monitoring.

Knowledge Gaps Affected Liver Cancer Surveillance

HCC surveillance faced knowledge and access barriers, with only 15% of patients identifying liver cancer detection as its purpose.